Mizuho Securities Co. Ltd. Takeda Pharmaceutical CO LTD Transaction History

Mizuho Securities Co. Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$13.12 - $15.03 $868,268 - $994,670	-66,179 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$16.3 - $17.26 $45,737 - $48,431	2,806 Added 4.43%	66,179 $1.08 Million
Q2 2021 Aug 05, 2021	SELL	$16.55 - $18.64 $1.24 Million - $1.4 Million	-75,172 Reduced 54.26%	63,373 $1.07 Million
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $2.32 Million - $2.76 Million	138,545 New	138,545 $2.53 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $3.33 Million - $4.1 Million	-216,270 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$17.1 - $19.19 $3.12 Million - $3.5 Million	182,370 Added 537.96%	216,270 $3.86 Million
Q2 2020 Aug 04, 2020	BUY	$14.59 - $19.5 $494,601 - $661,050	33,900 New	33,900 $515,000

323

70.5M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.